Matt Posard

(Mr. Matthew Posard)

Matt Posard's trades of Halozyme Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-08-14 2024-08-14 S Sale
9,881 -12.4%
57.70
USD 570,134
9,881 -12.4% 57.70 USD 570,134
2024-08-14 2024-08-13 S Sale
10,000 -11.1%
56.19
USD 561,930
10,000 -11.1% 56.19 USD 561,930
2024-08-14 2024-08-12 S Sale
10,000 -10.0%
55.72
USD 557,230
10,000 -10.0% 55.72 USD 557,230
2024-06-13 2024-06-12 S Sale
10,000 -9.1%
50.62
USD 506,190
10,000 -9.1% 50.62 USD 506,190
2024-06-13 2024-06-11 S Sale
10,000 -8.4%
50.01
USD 500,110
10,000 -8.4% 50.01 USD 500,110
2022-12-06 2022-12-06 S Sale
10,000 -8.7%
56.12
USD 561,180
10,000 -8.7% 56.12 USD 561,180
2022-12-06 2022-12-05 S Sale
10,000 -8.0%
55.74
USD 557,370
10,000 -8.0% 55.74 USD 557,370
2022-12-06 2022-12-02 S Sale
10,000 -7.4%
58.80
USD 588,000
10,000 -7.4% 58.80 USD 588,000
2021-12-01 2021-12-01 B Purchase
10,000 +25.0%
4.45
USD 44,493
10,000 +25.0% 4.45 USD 44,493
2021-12-01 2021-12-01 B Purchase
10,000 +33.3%
4.46
USD 44,612
10,000 +33.3% 4.46 USD 44,612
2021-12-01 2021-12-01 B Purchase
10,000 +50.0%
4.50
USD 45,000
10,000 +50.0% 4.50 USD 45,000
2021-12-01 2021-11-30 B Purchase
20,000 +inf%
4.57
USD 91,400
20,000 +inf% 4.57 USD 91,400
2021-02-19 2021-02-17 B Purchase
62,500 +inf%
16.00
USD 1,000,000
62,500 +inf% 16.00 USD 1,000,000
2021-01-13 2021-01-11 B Purchase
33,898 +64.0%
29.50
USD 999,991
33,898 +64.0% 29.50 USD 999,991
// ... existing code ... // ... rest of the file ...